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Altered Co-Translational Processing
Plays a Role in Huntington’s
Pathogenesis—A Hypothesis
Daniel A. Nissley and Edward P. O’Brien*
O’Brien Lab, Department of Chemistry, The Pennsylvania State University, University Park, PA, USA
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused
by the expansion of a CAG codon repeat region in the HTT gene’s first exon that results in
huntingtin protein aggregation and neuronal cell death. The development of therapeutic
treatments for HD is hindered by the fact that while the etiology and symptoms of HD are
understood, the molecular processes connecting this genotype to its phenotype remain
unclear. Here, we propose the novel hypothesis that the perturbation of a co-translational
process affects mutant huntingtin due to altered translation-elongation kinetics. These
altered kinetics arise from the shift of a proline-induced translational pause site away
from Htt’s localization sequence due to the expansion of the CAG-repeat segment
between the poly-proline and localization sequences. Motivation for this hypothesis
comes from recent experiments in the field of protein biogenesis that illustrate the critical
role that temporal coordination of co-translational processes plays in determining the
function, localization, and fate of proteins in cells. We show that our hypothesis is
consistent with various experimental observations concerning HD pathology, including
the dependence of the age of symptom onset on CAG repeat number. Finally, we suggest
three experiments to test our hypothesis.
Keywords: biophysics, Huntington’s disease, kinetics, neurodegenerative disease, protein aggregation,
translation, translation regulation, protein biogenesis
INTRODUCTION
Huntington’s disease is an autosomal dominant neurodegenerative disorder characterized by the
death of striatal neurons and the appearance of aggregates in the nuclei of a wide range of brain
tissues (Davies et al., 1997; Tobin and Signer, 2000). Physical symptoms of HD include chorea
(involuntary, dance-like motor function) and the dementia-like decline of mental faculties (Tobin
and Signer, 2000). The genetic cause of HD is the expansion of a CAG codon repeat in Exon 1 of
the HTT transcript; persons without HD have on average 19 CAG repeats, while individuals with
35 or more CAG repeats will develop HD symptoms over a typical lifespan (Squitieri et al., 1994;
Brinkman et al., 1997; Lee et al., 2012). Each additional CAG repeat beyond 35 results in the onset
of symptoms roughly 3 years sooner, with repeat lengths greater than 60 leading to acute juvenile
onset (Brinkman et al., 1997; Li and Li, 1998; Lee et al., 2012).
The pathogenesis of HD is most likely due to one or more of the aberrant gain-of-function
(Yano et al., 2014) or loss-of-function (Atwal et al., 2007) behaviors that have been identified for
mutant huntingtin (mHtt) or the HTT transcript. Understanding themechanism of pathogenesis is
significantly complicated by the fact that the normal function of wild-type huntingtin protein (Htt)
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is not agreed upon (Cattaneo et al., 2005). Htt is composed of,
starting from the N-terminus, a 17-amino acid localization signal
(denoted N17) (Maiuri et al., 2013) that allows for the targeting
of Htt to subcellular organelles including the Golgi apparatus,
endoplasmic reticulum, and mitochondria (Rockabrand et al.,
2007). Next in the sequence are 19 glutamines (Squitieri et al.,
1994; Brinkman et al., 1997) (poly-glutamine) encoded by CAG
codon repeats. Following the poly-glutamine region is a 38 amino
acid proline-rich region (poly-proline) which contains a total of
28 prolines, including continuous stretches of 10 and 11 prolines
(Crick et al., 2013). These three sequence elements of N17, the
poly-glutamine region, and the poly-proline region, constitute
Htt Exon 1 (Crick et al., 2013). The characteristic aggregates
observed in HD patients are primarily constituted by small
fragments of Htt Exon 1 that aremost likely generated by abortive
degradation attempts or the translation of an Exon 1-only mRNA
produced due to aberrant splicing (Suhr et al., 2001; Chow
et al., 2012; Sathasivam et al., 2013). Recent evidence suggests
that C-terminal mHtt fragments can also lead to toxic effects
by inhibiting the protein dynamin 1, leading to endoplasmic
reticulum stress (El-Daher et al., 2015). The remainder of the
3144 residues in Htt consist of approximately 40 HEAT repeats,
which are conserved helix-turn-helix structure motifs (Cattaneo
et al., 2005) each roughly 40 residues in length. The only
difference between the primary structure of mHtt and Htt, and
the genetic cause of HD pathology, is that mHtt contains an
expansion of the poly-glutamine region of Exon 1 to 35 or more
glutamines.
Since the discovery in 1993 that HD is caused by CAG-
repeat expansion in Htt Exon 1, no dominant hypothesis for HD
pathogenesis has emerged. Instead, many interrelated hypotheses
have been put forward that variously describe HD as the result
of dysfunction at the protein (Truant et al., 2006) or mRNA
(McLaughlin et al., 1996) level, to be associated with subcellular
organelles like the mitochondria (Yano et al., 2014) or systems
such as the ubiquitin-proteasome system (Chow et al., 2012), and
to be due to either loss- or gain-of-function (Gil and Rego, 2008).
Each of these hypotheses can explain some subset of the diverse
set of experimental observations of HD pathogenesis and mHtt
behavior, though the overall picture remains unclear. Despite
this complex and overlapping set of hypotheses, new hypotheses
continue to emerge that can explain more diverse, or previously
disparate, sets of observations.
Here, we propose the novel hypothesis that co-translational
processing plays a role in HD pathogenesis. This hypothesis
is motivated by recent experimental results demonstrating
that many of the behaviors of nascent proteins, including
their targeting and aggregation, can be altered by changes to
translation kinetics. We propose that a co-translational process
is perturbed for mHtt due to altered translation-elongation
kinetics downstream of N17. The magnitude of this perturbation
is directly proportional to the increase in the length of the
poly-glutamine sequence past Q35. Such perturbations to co-
translational processes have been shown to profoundly alter
downstream protein behavior, and the idea that there is a co-
translational element to Huntington’s pathogenesis is consistent
with the experimental literature. We describe the insights
gained from these studies and how they suggest a role for
co-translational processes in HD pathology. We show that
our hypothesis is consistent with a number of experimental
observations concerning mHtt behavior and HD pathogenesis.
We conclude by suggesting three experiments that directly test




A number of processes involving nascent proteins take place
during protein synthesis. These processes are therefore referred
to as co-translational processes, and include domain folding
(Nicola et al., 1999; Komar, 2008), chaperone interactions (Gloge
et al., 2014), translocation (Walter and Johnson, 1994; Pechmann
et al., 2013), ubiquitination (Comyn et al., 2013; Duttler et al.,
2013), phosphorylation (Oh et al., 2010; Keshwani et al., 2012),
acetylation (Polevoda and Sherman, 2000), and glycosylation
(Ruiz-Canada et al., 2009). The rates at which different nascent
chain segments are synthesized can affect these co-translational
processes, leading to altered nascent protein behavior in a
cell (Zhang et al., 2009; Siller et al., 2010; Pechmann et al.,
2014). These co-translational processes appear to occur far
from equilibrium, such that the kinetics of translation can be
more important than thermodynamics in determining nascent
protein behavior (Nissley and O’Brien, 2014). Perturbations
to these temporally-coordinated co-translational processes can
result in deleterious downstream effects such as protein
mistargeting (Kramer et al., 2009) and aggregation (Cortazzo
et al., 2002). Most literature examples of codon-translation-
rate-dependent phenomena are from prokaryotic organisms,
such as E. coli. However, the timing of translation is also
critical for nascent protein behavior in eukaryotic cells (Nissley
and O’Brien, 2014). Eukaryotic cells contain homologs or
molecules that carry out similar functions to those which act
co-translationally in prokaryotes. Furthermore, the principles
of non-equilibrium systems that underlie these phenomena are
organism-independent (Nissley andO’Brien, 2014). For example,
human cells contain a chaperone system homologous to the
DnaJ/DnaK chaperone system that assists protein folding in
prokaryotes.
Nascent Chain Interactions with Auxiliary
Factors Depend on Nascent Chain Length
Recent studies have shown that the interactions of ribosome
nascent chain (RNC) complexes with targeting complexes
(Noriega et al., 2014), enzymes (Sandikci et al., 2013), and
chaperones (Rutkowska et al., 2008) are carefully orchestrated
in cells, and that their equilibrium affinities for translationally-
arrested RNCs depend sensitively on nascent chain length. For
example, the signal recognition particle (SRP), a universally-
conserved ribonucleoprotein that targets nascent proteins
for translocation into the ER by selectively interacting
with conserved signal sequences, interacts with RNCs in a
nascent-chain-length-dependent manner (Noriega et al., 2014).
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Experiments have shown that SRP binds strongest to arrested-
RNCs of between 75 and 95 amino acids in length; outside this
region, the dissociation constant increases 3- to 24-fold (Noriega
et al., 2014). Interactions between nascent chains and chaperones
have also been shown to depend on nascent chain length. Trigger
factor (TF) is a molecular chaperone in E. coli which assists
the folding of nascent proteins by binding the ribosome during
translation and shielding the nascent protein from aberrant
interactions (Maier et al., 2005; O’Brien et al., 2012), helping
to prevent misfolding and aggregation (Hoffmann et al., 2010).
Similar to SRP, RNC/TF interactions are also optimal within
a narrow range of nascent chain lengths, with a nearly 5-fold
decrease in TF’s dissociation constant for a RNC harboring a
100-residue nascent chain in comparison to a 23-residue nascent
chain (Rutkowska et al., 2008). Nascent chain length is a key
factor affecting these co-translational processes.
Co-Translational Folding and Downstream
Function Depend on
Translation-Elongation Rates
During continuous translation in vivo, the dwell time of a
ribosome at a given nascent chain length depends on the rate at
which the codon in the A-site is decoded into an amino acid. The
ribosome does not translate all codons at the same rate due to a
variety of molecular factors (Fluitt et al., 2007; Stadler and Fire,
2011; Pop et al., 2014), and the variability in codon translation
rates across an mRNA’s coding sequence is a key parameter
that modulates nascent protein behavior. Barral and co-workers
found that “optimizing” the codon sequence of firefly luciferase
(FL) by replacing rare codons (which are thought to translate
more slowly than average) with common synonymous codons
resulted in a ∼55% decrease in specific activity in vivo (Spencer
et al., 2012). In the case of the fast-translating FL transcript,
the decrease in specific activity was accompanied by an increase
in the amount of aggregated FL, suggesting that accelerating
translation decreased FL’s ability to acquire its correct structure
and perform its intended function. Codon translation rates have
also been shown to play a key role in regulating the structure
and function of the N. crassa clock protein FRQ (Zhou et al.,
2013). Optimization of the wild-type FRQ translation-rate profile
resulted in the abolishment of N. crassa’s circadian rhythm and
a two-fold decrease in FRQ’s ability to interact with a binding
partner, suggesting that changes to FRQ’s translation-rate profile
altered its structure and function.
The Co-Translational Targeting of Nascent
Proteins Depends on
Translation-Elongation Rates
Codon translation rates influence other co-translational
processes in addition to nascent protein structure acquisition.
The ability of SRP to target nascent chains for translocation
depends not only on its equilibrium affinity for conserved N-
terminal signal sequences measured on arrested-RNCs (Zhang
and Shan, 2012), but also on the rate at which the signal sequence
emerges from the exit tunnel during continuous synthesis in a
cell. Globally decreasing codon translation rates increases the
amount of protein that SRP successfully translocates into the ER
(Zhang and Shan, 2012). A bioinformatic analysis (Pechmann
et al., 2014) also revealed that “non-optimal” codons are
systematically enriched in the genomes of nine yeast species 35–
40 codons downstream of SRP signal sequences. The location of
this downstream region would result in translational slowdown
while the signal sequence is connected to the ribosome by a
35–40 amino acid linker, which corresponds to the approximate
length of the ribosome exit tunnel (Yusupov et al., 2001), such
that translation will be slowed just as the signal sequence emerges
from the tunnel and SRP is sterically permitted to interact with it.
This slowdown is presumed to give SRP more time to recognize
and bind the signal sequence, ensuring that the nascent protein
is successfully targeted to, and translocated into, the ER.
Polyproline Stretches Slow-Down
Translation Elongation
The molecular origin of the observed variability of codon
translation rates is complex, including factors such as cognate
tRNA concentrations, the chemical nature of the amino acid
being added to the nascent chain (i.e., the nature of the amino
acid in the A-site), and sequence motifs within the nascent chain
(Pavlov et al., 2008; Artieri and Fraser, 2014). For example, it
has been well-established that poly-proline regions slow down
translation. In vitro (Pavlov et al., 2008) and in vivo (Artieri and
Fraser, 2014) experiments have demonstrated that the ribosome
translates sequences of two or more prolines much slower than
the average global translation rate.
The results we have discussed highlight how critical the timing
of translation can be to co-translational phenomena and to
determining downstream protein behavior in a cell.
THE HYPOTHESIS: ALTERED
CO-TRANSLATIONAL PROCESSES
INVOLVING HUNTINGTIN PLAY A ROLE IN
HD PATHOLOGY
Our hypothesis for the contribution of co-translational processes
to HD pathogenesis naturally follows from these experimental
observations of protein biogenesis. In Htt, stretches of prolines
are optimally positioned 30–57 residues downstream of N17 to
slow translation-elongation when N17 has just been exposed
from the confines of the ribosome exit tunnel, which may also
be the optimal length at which the binding between a co-
translationally acting factor (CAF) and the nascent chain is
strongest (Figure 1). These proline residues are highly conserved,
being present in the huntingtin proteins of all higher vertebrates
(Cattaneo et al., 2005). This slowdown of translation provides
time for an as-yet-unidentified (and unlooked-for) CAF to
interact with the nascent chain and either help direct it to its
proper subcellular location or chemically modify the nascent
chain as needed for its function. In the case of mHtt, however,
the expanded poly-glutamine region, rather than the poly-proline
region, will be undergoing translation as the N17 sequence
emerges from the ribosome exit tunnel; translation of these
glutamines (encoded by CAG) is two- to six-fold faster than
translation of the prolines located at these same codon positions
in the wild-type (Pavlov et al., 2008; Artieri and Fraser, 2014),
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and the CAF will thus have less time to bind N17 at the strongest-
binding nascent chain lengths. A key concept in this hypothesis is
that for each additional CAG repeat added to the poly-glutamine
region there is a proportional decrease in the time available for
the CAF to bind N17 at the nascent-chain lengths for which it has
the strongest binding affinity at equilibrium. As a result, for each
additional CAG repeat a smaller fraction of mHtt will interact
with the CAF, andmore mHtt will therefore have the opportunity
to act aberrantly and form aggregates.
This hypothesis is consistent with nine key Experimental
Observations concerning HD and mHtt:
Experimental Observation 1: The brains of HD patients
contain protein aggregates in cell nuclei (DiFiglia et al.,
1997; Huang et al., 1999). The main constituents of these
characteristic aggregates are fragments of mHtt Exon 1 (Suhr
et al., 2001). In the cytosol, mHtt is targeted for degradation by
either chaperone-mediated autophagy (Qi and Zhang, 2013)
or the ubiquitin/proteasome system (UPS) (Chow et al., 2012).
Explanation 1:As the number of CAG repeats increases, more
mHtt is co-translationally misprocessed and directed to the
cytosol. The UPS’ ability to clear mHtt decreases over time
(Seo et al., 2004; Hunter et al., 2007), and it also has trouble
completely degrading proteins with repetitive sequence
elements like mHtt’s poly-glutamine region (Fishbain et al.,
2015). These problems with degradation combine with the
increased partitioning of mHtt into the cytosol to increase
the quantity of mHtt fragments in the cell, thereby making
it more likely that they may enter the nucleus and aggregate
or otherwise act aberrantly (Atwal et al., 2007). This increase
in cytosolic mHtt may also lead to an increase in the quantity
of C-terminal fragments that cause ER stress (El-Daher et al.,
2015).
Experimental Observation 2: Only persons with 35 or more
CAG repeats develop HD symptoms (Squitieri et al., 1994;
Brinkman et al., 1997; Lee et al., 2012).
Explanation 2: If nascent Htt contains >35 CAG repeats,
the poly-proline region is not positioned to slow translation
as N17 emerges from the ribosome exit tunnel. Inefficient
processing results due to decreased CAF binding, leading
to the accumulation of mHtt in the cytosol and subsequent
aggregation.
Experimental Observation 3: Each additional CAG repeat
beyond 35 speeds disease progression by roughly 3 years
(Squitieri et al., 1994; Brinkman et al., 1997; Lee et al., 2012).
Explanation 3: As the number of CAG repeats increases over
35, targeting becomes proportionally less efficient, impaired
by the decreased time available for the CAF to bindmHtt’s N17
sequence (see Figure 2). This decreased targeting efficiency
results in an increased flux of mHtt into the cytosol, increasing
the rate of aggregate formation.
Experimental Observation 4: N17 is required for the correct
targeting of Htt to subcellular organelles (Rockabrand et al.,
2007); the removal of N17 has been shown to completely
abolish the targeting of Htt to themitochondria, ER, and Golgi
apparatus.
Explanation 4: CAFs can be sequence specific (Zhang and
Shan, 2012), identifying motifs like conserved patterns of
hydrophobic and charged residues (Xia et al., 2003). If N17
is absent, then there is nothing for the CAF to recognize
and bind, resulting in the inefficient targeting of mHtt to
subcellular organelles (Rockabrand et al., 2007).
Experimental Observation 5: Removal of N17 leads to a large
increase in the rate of nuclear aggregate formation in a HD
mouse model, despite lower expression levels (Gu et al., 2015).
Explanation 5: Removal of N17 effectively abolishes targeting
of nascent Htt to subcellular organelles (see Experimental
Observation 4). The1N17 deletion mutant of mHtt therefore
remains in the cytosol for an extended period of time, further
burdening the UPS and speeding the formation of the Exon 1
fragments that form nuclear aggregates or of the C-terminal
fragments that induce ER stress (Suhr et al., 2001; El-Daher
et al., 2015).
Experimental Observation 6: The length of the poly-
glutamine region alters Htt targeting (Rockabrand et al.,
2007). Increasing the length of the poly-glutamine domain
from 25 to 97 Q’s reduces co-localization of the protein to the
mitochondria, ER, and Golgi by 4, 10, and 30%, respectively.
Explanation 6: Expansion of the poly-glutamine sequence
moves the poly-proline stretch further downstream,
disrupting the wild-type translation-elongation schedule.
Without the poly-proline region to slow translation at
the proper time, N17 is less likely to correctly interact
with a CAF, in turn reducing the amount of correctly
localized mHtt.
Experimental Observation 7: The presence of the poly-
proline region is critical for correct targeting (Rockabrand
et al., 2007). Removal of the poly-proline region reduces the
co-localization of the protein to the ER and Golgi by 30 and
25%, respectively.
Explanation 7: Complete removal of the poly-proline region
significantly perturbs the wild-type translation-rate profile of
Htt. There will be less time available for a CAF to interact
with N17, decreasing the probability of correct targeting and
downstream function.
Experimental Observation 8: Removal of the poly-proline
region is detrimental to spatial learning and memory in a
mouse model of HD (Neveklovska et al., 2012).
Explanantion 8: As described in Experimental Observation
7, removal of the poly-proline region leads to an increase
in the quantity of Htt which is unable to perform its
correct downstream function, leading to the observed disease
symptoms.
Experimental Observation 9: A fusion protein consisting of
the first 171 amino acids of Q125 mHtt attached to GFP has a
shorter soluble half-life than an analogous Htt171-GFP fusion
protein (Kaytor et al., 2004).
Explanation 9: This decreased solubility is due to perturbed
co-translational processing, which can result in poor targeting
to subcellular organelles that may increase aggregation
propensity and result in a decreased soluble half life (Cortazzo
et al., 2002).
Frontiers in Molecular Neuroscience | www.frontiersin.org 4 July 2016 | Volume 9 | Article 54
Nissley and O’Brien Co-Translational Hypothesis of Huntington’s Pathogenesis
FIGURE 1 | The proposed co-translational mechanism of HD pathology. (1) A CAF (orange) recognizes N17 (blue rectangle) of nascent Htt (top, nascent
proteins shown in green, ribosome in gray). In the case of mHtt (bottom), the poly-proline region is not correctly positioned to slow translation as N17 emerges,
reducing the ability of the CAF to bind. (2) In the case of Htt, the CAF directs the subcellular localization of Htt to the Golgi, ER, and mitochondria. Enzymatic
modifications (not shown) may occur between targeting and localization, as is known to occur for some proteins in E. coli (Sandikci et al., 2013). mHtt is largely
directed to the cytosol, where proteolysis (3) produces short, Exon 1-containing fragments (short green line segments) that form amyloid. Proteolysis can also result in
C-terminal mHtt fragments that interfer with ER function (El-Daher et al., 2015).
Though other hypotheses for HD pathology can explain
different subsets of these observations, our hypothesis is the only
one (Zuccato et al., 2003; Cornett et al., 2005; Atwal et al., 2007;
Nalavade et al., 2013; Yano et al., 2014) that, to our knowledge,
is consistent with the experimentally-observed dependence of
proper Htt targeting on the presence of the N17, poly-glutamine,
and poly-proline sequence motifs. Our hypothesis is also unique
in offering a molecular explanation for why removal of the N17
or poly-proline sequences leads to the development of disease
symptoms.
OUR HYPOTHESIS IN THE CONTEXT OF
OTHER MECHANISMS THAT COULD
CONTRIBUTE TO mHtt PATHOLOGY
Many hypotheses have been proposed (McLaughlin et al.,
1996; Zuccato et al., 2003; Cornett et al., 2005; Atwal et al.,
2007; Rockabrand et al., 2007; Chow et al., 2012; Nalavade
et al., 2013; Yano et al., 2014) (a partial list) that can explain
different groupings of the nine experimental observations of
HD pathogenesis and Htt behavior we list above. We cannot
succinctly describe the full complexity of these interrelated
theories. However, given the complexity of HD pathogenesis, it
seems reasonable that each of these mechanisms has the potential
to contribute in some way to the disease phenotype.
None of the other hypotheses that offer explanations for
Experimental Observations 1–9 are mutually exclusive with the
model that we have described. For example, the hypothesis
that mHtt toxicity is mRNA-mediated (McLaughlin et al., 1996;
Nalavade et al., 2013) posits that large CAG-repeat lengths in
HTT can cause toxic downstream effects by forming a stable
mRNA hairpin that sequesters a diverse set of proteins. Our
co-translational hypothesis of HD pathogenesis can co-exist
with this hypothesis. Consider one implication of the RNA-
mediated hypothesis: at high values of NCAG a hairpin can form
in HTT that recruits various cellular factors, including protein
kinase R (PKR) (Peel, 2004). PKR is a double-stranded RNA-
dependent kinase that forms part of the cellular virus-defense
system, and its activation is associated with myriad downstream
cell stress and apoptosis events including the upregulation of
proteolysis machinery (Peel, 2004). Simultaneously, perturbation
of co-translational processes may increase the fraction of mHtt
directed to the cytosol (Figure 1), such that both processes
synergistically contribute to an increase in the quantity of
mHtt fragments observed in vivo. This explanation also
demonstrates the interplay between our hypothesis and the
hypothesis that proteolysis of mHtt is key to pathogenesis,
as perturbed co-translational interactions that increase the
amount of mHtt directed to the cytosol would also increase
the stress on the cell’s proteolysis machinery (Chow et al.,
2012).
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FIGURE 2 | A simple chemical-kinetic model explains how the age of onset of HD symptoms could arise from disruption of co-translational processing
of huntingtin. (A) The CAF is assumed to bind N17 irreversibly in the region of optimal binding with rate kon. (B) Within this model, the CAF can only bind when the
nascent Htt molecule is between 52 and 71 amino acids in length (i.e., when the ribosome starts translating the poly-proline region). (C) As NCAG increases the
number of glutamines (Q) in the binding region increases and the number of prolines (P) decreases, leading to a decrease in the time available for CAF binding (τAFB).
τAFB has units of τA (see Methods). (D) The fraction of Htt that is co-translationally misprocessed depends on τAFB and, thereby, on NCAG, as expressed by Equation
1. (E) The fraction of Htt which is misprocessed (fmp in Equation 1) strongly correlates with NCAG when realistic values for kon and CAF concentration are used (see
Methods for a complete description of Equation 1). (F) The age of HD symptom onset shows strong negative correlation with the fraction of Htt misprocessed
predicted by Equation 1. Age of onset vs. NCAG data were extracted from Figure 1C of Lee et al. (2012) with PlotDigitizer (plotdigitizer.sourceforge.net).
Repeat-associated non-ATG translation initiation of the
mHtt transcript may also be related to our co-translational
hypothesis. The frameshift created by this non-canonical
translation initiation process will alter the identity of the codons
being translated and also result in a nascent protein without
the N17 localization sequence (Nalavade et al., 2013). These
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two consequences of non-ATG translation initiation constitute
a significant alteration to codon elongation rates and co-
translational behavior that may contribute to HD pathology.
Consider also that our hypothesis is independent of the method
of mHtt fragment generation. Whether pathogenic fragments are
a result of proteolysis or of aberrant mRNA splicing of Exon1,
translation will still occur, and co-translational phenomena can
thus still be critical. Experiments have also shown that the MID1-
PP2A regulatory complex binds the mRNA hairpin formed by
the expanded CAG-repeat region of mutant HTT, increasing the
rate of translation initiation (Krauss et al., 2013). This increase
in translation initiation for the mutant transcript increases the
amount of mHtt translated, increasing the amount of protein
that may be co-translationally misprocessed according to our
hypothesis.
As previously mentioned, ours is the only hypothesis, to
our knowledge, that can explain the experimentally-observed
influence of the N17, poly-glutamine, and poly-proline regions
on the sub-cellular localization of Htt and mHtt, the large
increase in nuclear aggregation when N17 is deleted, and
the relationship between poly-proline deletion and various
negative effects (Experimental Observations 4–8). The ability
of our hypothesis to explain the large increase in aggregation
rate observed when mHtt lacking N17 is expressed in vivo
(Experimental Observation 5) is particularly important. In vitro
studies have demonstrated that the aggregation rate of purified
poly-glutamine segments increases as the number of poly-
glutamine residues increases (Scherzinger et al., 1999). Occam’s
Razor suggests, then, that our co-translational phenomenon
based hypothesis may be superfluous. However, this simpler
hypothesis cannot explain the observed increase in aggregation
in vivo upon N17 deletion, whereas our hypothesis can.
A KINETIC MODEL BASED ON THIS
HYPOTHESIS SUGGESTS WHY THE AGE
OF ONSET OF HD SYMPTOMS
NEGATIVELY CORRELATES WITH THE
NUMBER OF CAG REPEATS
We can express this hypothesis in terms of the chemical reaction
scheme shown in Figure 2A, in which we assume that a CAF only
binds nascent Htt in a narrow range of nascent chain lengths
with rate kon. This reaction scheme can be solved analytically
using the principles of chemical kinetics to give an equation
that estimates the change in the fraction of misprocessed nascent
mHtt (fmp) as the number of CAG repeats (NCAG) increases
above 35. By misprocessed we mean mHtt fails to interact with
the CAF; for the purposes of this simple model, we assume
that this co-translational interaction is an obligate step in Htt’s
normal protein maturation pathway. To derive this equation
we make the simplifying assumptions that (i) the binding of
the hypothesized CAF to N17 is irreversible in the region of
optimal binding, (ii) kon is non-zero from codon position 53,
when translation of the poly-proline region begins for Q35-
Htt, to codon position 72 (corresponding to nascent chain
lengths 52–71, see Figure 2B and Methods), and (iii) prolines
are translated twice as slowly as glutamines (Figure 2C and
Methods). Assumptions (ii) and (iii) have experimental support
in the literature, as described in the Methods. With these
assumptions, fmp (see Methods for a complete description of this
kineticmodel and its technical assumptions), which calculates the
relative fraction of Htt misprocessed at NCAG in comparison to
the amount misprocessed when NCAG = 35, can be expressed as
fmp(NCAG) = exp
[
−kon (τAFB (NCAG)− τAFB (35))
]
− 1. (1)
In Equation (1), τAFB is the total amount of time available
for CAF binding at the optimal nascent-chain binding lengths,
which is a function of NCAG (Figure 2C). As τAFB decreases the
fraction of misprocessed Htt increases (Figure 2D). Figure 2E
displays the results obtained from Equation (1) when a realistic
value for kon (see Methods) is used to calculate fmp for values
of NCAG from 40 to 53. We find that fmp strongly correlates
with NCAG
(
Pearson R2 = 0.996, p = 1× 10−15
)
. Furthermore,
we find that the experimentally-determined age of HD symptom
onset also strongly correlates with fmp (PearsonR
2
= 0.962, p =
7 × 10−10, Figure 2F). This latter correlation is consistent with
our hypothesis that a defect in a co-translational process plays
a role in HD pathogenesis. Strong correlations are also found
between our kinetic model and the age of onset data presented by
Brinkman et al. (1997) for NCAG values of 39–50 (fmp vs. NCAG:
Pearson R2 = 0.997, p = 7 × 10−14; Age of onset vs. fmp:
Pearson R2 = 0.958, p = 3 × 10−8, data not shown) (Brinkman
et al., 1997).
ON THE NATURE OF MISPROCESSING
With over 11 different co-translational processes potentially
acting on huntingtin, any one or more of them may be perturbed
by altered translation-elongation kinetics due to CAG expansion.
We believe, however, that the two most-likely culprits are (i)
altered co-translational phosphorylation of N17 by a CAF or (ii)
decreased binding of a CAF that targets Htt to its proper cellular
location.
Consider, for example, the influence that CAG-repeat
expansion could have on the phosphorylation of Htt at serine
positions S13 and S16 within N17 and, thereby, on downstream
Htt behavior such as membrane binding. Experiments have
demonstrated that the phosphorylation of these two serine
residues is important for the cellular localization of Htt
(Atwal et al., 2011; Maiuri et al., 2013) and also plays a
role in determining if Htt will be targeted for degradation
by the ubiquitin/proteasome system (UPS) (Thompson et al.,
2009). Critically, mHtt has also been experimentally shown
to have decreased levels of phosphorylation in comparison
to Htt (Atwal et al., 2011). Such changes in phosphorylation
state have been shown to influence the binding affinity of
peptides for membranes (Dehlin et al., 2008). Our hypothesis
can succinctly explain these observations. The N-terminal
location of S13 and S16 within huntingtin means that the time
available for co-translational phosphorylation will decrease as
the number of CAG repeats increases (see Figures 2C,D). In
the case of Htt, the poly-proline sequence is correctly placed
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to slow translation as N17 emerges, allowing time for the
phosphorylation of the serines and subsequent downstream
localization and function of Htt. In the case of mHtt, however,
co-translational phosphorylation is perturbed by the decrease in
time available for CAF binding introduced by the expansion of
the CAG-repeat region, resulting in a decrease in the fraction
of mHtt which is correctly phosphorylated and can perform its
correct downstream function. An analogous mechanism can be
postulated for each of the N-terminal processing events which
may affect Htt co-translationally, such as N-terminal acetylation
and phosphorylation of Thr3 (Aiken et al., 2009). It is important
to note that this example assumes N17 phosphorylation occurs
co-translationally; while there is evidence that this is the case for
some proteins (Oh et al., 2010; Keshwani et al., 2012), whether
or not Htt is co-translationally phosphorylated has not yet been
investigated.
TESTING THE CO-TRANSLATIONAL
MISPROCESSING HYPOTHESIS OF HD
PATHOLOGY
Though our hypothesis is consistent with a wide range of
experimental observations concerning HD pathogenesis, it
is based on a large body of circumstantial evidence from
the co-translational folding field. We therefore suggest three
experiments that would test this model. First and foremost, it
must be determined if a CAF engages Htt. This question can be
answered with a combination of pulse-chase labeling and cross-
linking assays. Pulse-chase assays have been used extensively
to study co-translational protein folding, as they provide the
ability to specifically visualize nascent proteins (Braakman et al.,
1991; Nicola et al., 1999), while chemical crosslinking has also
been used to capture RNC/CAF complexes in situ (Oh et al.,
2011). We suggest that these two techniques be combined
into a hybrid technique. A short pulse-period of radiolabel
incorporation (<1min) would be followed by a chase period
with unlabeled media containing a crosslinking agent (such as
dithiobis succinimidyl propionate Oh et al., 2011) to selectively
label nascent Htt and capture its interactions with any CAFs,
respectively. Similar methods utilizing the incorporation of non-
canonical amino acids into Htt followed by photo-crosslinking
(Mackinnon et al., 2007) or click chemistry (Dieterich et al.,
2007) to connect Htt to binding partners can also be envisioned,
though these methods require chemical modification of N17
that may alter the ability of potential binding partners to
recognize and bind Htt Exon 1 (Maiuri et al., 2013). The
experiment would conclude with size-dependent separation by
SDS-PAGE and gel visualization via phosphorimaging or with
mass spectrometry, depending on the technique used. Pending
the positive identification of a Htt/CAF interaction, the next
relevant question is whether this CAF preferentially binds Htt
over mHtt. This question can be straightforwardly answered via
the application of a number of different experimental techniques
for determining dissociation constants as well as the on and off
rates of RNC/CAF binding (Rutkowska et al., 2008).
Our hypothesis suggests that the amount of mHtt directed
to the cytosol (i.e., the amount of nascent protein that is
mistargeted or otherwise malfunctions and is available for
proteolysis) is greater than the amount of Htt directed to the
cytosol. Furthermore, our hypothesis predicts that the amount of
mHtt directed into the cytosol will be a monotonically-increasing
function of poly-glutamine length. Though the subcellular
localization of various Htt Exon 1 constructs has been previously
reported (Rockabrand et al., 2007), these data are not sufficient
to quantify the flux of Htt/mHtt into the cytosol. Similar
experiments could be designed utilizing separate fluorescent tags
for each relevant organelle (i.e., the Golgi, ER, andmitochondria)
as well as for the Htt construct. The fraction of cytosolic
protein at various times after the start of the experiment could
then be calculated by the difference between the total Htt-
associated fluorescence and the Htt-associated fluorescence that
co-localized with subcellular organelles.
CONCLUSION
We have described a novel hypothesis that presents possible
contributions to HD pathology due to perturbation of the
non-equilibrium phenomena of co-translational nascent-protein
processing. Within this model, N17 is the CAF binding site, the
poly-glutamine region acts as a linker connecting N17 to the
poly-proline region, and the poly-proline stretch acts as a brake
on translation elongation that facilitates N17-CAF interactions.
As the number of CAG repeats increases above 35, the poly-
proline stall site shifts further and further downstream of N17,
and due to the decreased time available for CAF binding, more
mHtt fails to be correctly co-translationally modified or targeted
and is therefore directed to the cytosol. In the cytosol, proteolysis
can result in the production of Exon 1 or C-terminal fragments
that form HD’s characteristic nuclear amyloid (Suhr et al., 2001;
Chow et al., 2012) or cause ER dysfunction (El-Daher et al.,
2015), respectively. There is precedence for such an effect for
other proteins; codon translation rates have been implicated as
causal factors in the development of some human cancers (Supek
et al., 2014; Zheng et al., 2014), cystic fibrosis (Bartoszewski
et al., 2010), and disparate drug transport functionalities between
synonymous mutant proteins (Kimchi-Sarfaty et al., 2007). Our
hypothesis is consistent with key observations of mHtt behavior
and HD pathology (Figures 1, 2). Furthermore, our hypothesis
is testable, and we have suggested a number of experiments that
do so.
Pending the identification of a CAF that interacts with
mHtt new therapeutic strategies can be explored based on
the idea of reducing the rate of poly-glutamine translation to
provide the needed time for CAF binding. Though we have
thoroughly investigated our co-translational hypothesis only
for HD, five other poly-glutamine proteins associated with
the neurodegenerative disorders SBMA, DRPLA, SCA-2, SCA-
3, and SCA-7 also contain poly-proline regions (The Uniprot
Consortium, 2015). Therefore, it is possible that these other
proteins might also have a contribution to their pathology due
to changes to co-translational phenomena upon poly-glutamine
expansion. However, given the differences between these other
poly-glutamine proteins and Htt, the specific form of this effect is
likely different. It is our hope that the novel perspective offered
in this paper will motivate experimentalists to further explore
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the molecular biophysics of HD pathology and any connection
to translation kinetics and nascent protein behavior.
METHODS
Derivation of Chemical-Kinetic Model for
Htt Misprocessing
CAF binding tends to be favored in a narrow range of nascent
chain lengths. For example, equilibrium binding data show that
SRP’s affinity for arrested RNCs is optimal within a ∼20 amino-
acid region (Noriega et al., 2014). Outside this optimal region, the
KD increases by 3- to 24-fold. Therefore, in our chemical kinetic
reaction scheme (Figures 2A,B) we allow CAF/N17 binding only
in a narrow range of nascent chain lengths by assuming that kon
is zero except between codon positions 53–72. We also assume
that koff is equal to zero, which approximates a binding process
that heavily favors association over dissociation in the region
of optimal binding. The ribosome first encounters the codons
encoding the poly-proline region at codon 53 in Htt with a 35-
residue poly-glutamine region. We therefore take position 53,
somewhat arbitrarily, as the start of the CAF binding region
(Figure 2B), which extends to codon position 72. Increasing
the width of this optimal-binding region does not influence
the results obtained in the calculation of Equation (1) (data
not shown). In reality, the nascent chain length regime over
which a CAF prefers to engage nascent Htt may be significantly
different than that which we use here. Under these assumptions




can be expressed as a
function of the total time available for CAF binding (τAFB, the
dwell time of the RNC in the optimal-binding region). These











Amp (τAFB = 0) is the amount of Htt misprocessed when there is
no time available for CAF binding. The value of τAFB depends
on NCAG and is the total time required by the ribosome to
decode codons i = 53 to i = 72 (Figure 2C). For simplicity,
we assume that there are two types of codons, faster-translating
codons, which are decoded in time τA, and slower-translating
codons, which are decoded in time 2τA (Figure 2C). Codons in
the poly-glutamine region are defined to be faster-translating,
while codons in the poly-proline region are defined to be slower-
translating. Thus, τAFB decreases by an increment of τA for
each CAG repeat past 35 (Figure 2C). Experimental reports
suggest that proline codons require between two and six times
longer to translate than the global average codon translation
time (Pavlov et al., 2008; Artieri and Fraser, 2014). Figures 2E,F
display the results when we use the smallest difference suggested
by the literature of a two-fold increase in translation time of
prolines. Equation 1 gives strong correlations when translation
times between 2τA and 6τA are used (data not shown). As NCAG
increases over 35 and τAFB decreases, the fraction of nascent Htt
which is incorrectly processed increases (Figure 2D). In order
to avoid the issue of estimating a value for Amp (τAFB = 0), we




at NCAG relative to the amount of Htt misprocessed at NCAG =
35,
fmp(NCAG) =














Algebraic simplification of Equation (3) yields Equation (1),
which gives the fraction of misprocessed Htt as a function of
NCAG and does not depend on Amp (τAFB = 0). Equation (1) is
linear for small arguments of the exponential term. Consider the
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For values of x≪1, the n > 1 terms in Equation 4 are vanishingly
small, and exp (x) is reasonably linear. We also note that altering
the width and/or location of the optimal-binding region will alter
the range of NCAG values over which fmp is a monotonically-
increasing function. Once NCAG increases such that all codons
in the optimal-binding region encode Q and not P, τAFB is
minimized and fmp remains constant. With the sample numbers
used here, τAFB reaches aminimum value of 20 atNCAG = 55 (see
Figure 2C), such that fmpbecomes constant when NCAG ≥ 55.
Calculation of kon For the Chemical Kinetic
Model
Equation (1) requires a rate constant for CAF/RNC binding
in order to predict fmp. Binding rates are available in the
literature for several different CAFs, including trigger factor,
signal recognition particle, DnaK, and DnaJ. The rates reported
in the literature typically have units of M−1s−1, indicating a
dependence on both the cellular concentration of the CAF and
time. First, we selected the kon rate measured for DnaJ of
3.3 × 105 M−1s−1 (Powers et al., 2012). Next, we determined a
reasonable estimate for the intracellular concentration of DnaJ
in human cells. Finka and Goloubinoff (2013) recently reported
intracellular concentrations for 147 molecular chaperones in
HeLa cells. We generated a reasonable estimate of the DnaJ
intracellular concentration by taking the median of the cellular
concentrations of the subset of 109 chaperones which were
identified to be cytosolic or nuclear. This median value is
1.11× 10−7 M (assuming an average HeLa cell volume of 2600
µm3 Finka and Goloubinoff, 2013). Multiplying the on rate for
DnaJ by this concentration yields the in vivo kon estimate used in
Eq. 1 of 0.0366 s−1.
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